» Articles » PMID: 12689846

Quadriceps Fatigability After Single Muscle Exercise in Patients with Chronic Obstructive Pulmonary Disease

Overview
Specialty Critical Care
Date 2003 Apr 12
PMID 12689846
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to compare quadriceps fatigability in patients with varying severity of chronic obstructive pulmonary disease with age-matched control subjects. Ten healthy control subjects, 8 patients with severe disease (FEV1 less than 35% predicted), and 11 patients with mild to moderate disease were studied. The FEV1 was 1.75 +/- 0.13 L (SE), 50.4 +/- 2.9% of predicted in the mild to moderate group, and 0.87 +/- 0.06 L, 25.9 +/- 1.9% of predicted in the severe group. Quadriceps fatigue was quantified by the reduction in potentiated twitch force after a potentially fatiguing task. All subjects performed three sets of 10 maximum voluntary contractions of the right quadriceps muscle. Quadriceps maximum voluntary contraction force was 58.3 +/- 3.3 kg for the healthy older group, 49.0 +/- 4.2 kg in the mild to moderate group, and 44.3 +/- 4.7 kg in the severe group. The fall in potentiated twitch force after exercise was significantly greater in the patients with severe disease than in the healthy control subjects. In conclusion, the quadriceps in patients with severe chronic obstructive pulmonary disease are more fatigable than those in age- and sex-matched healthy control subjects.

Citing Articles

Updated Perspectives on the Role of Biomechanics in COPD: Considerations for the Clinician.

Yentes J, Liu W, Zhang K, Markvicka E, Rennard S Int J Chron Obstruct Pulmon Dis. 2022; 17:2653-2675.

PMID: 36274993 PMC: 9585958. DOI: 10.2147/COPD.S339195.


Relationship between perceived and neuromuscular fatigue in COPD patients with chronic respiratory failure with long-term oxygen therapy: a cross-sectional study.

Paneroni M, Vitacca M, Comini L, Salvi B, Saleri M, Schena F Eur J Appl Physiol. 2022; 122(11):2403-2416.

PMID: 35951129 DOI: 10.1007/s00421-022-05021-2.


A randomized, crossover, placebo controlled, double-blind trial of the effects of tiotropium-olodaterol on neuromuscular performance during exercise in COPD.

Cao M, Calmelat R, Kierstead P, Carraro N, Stringer W, Porszasz J J Appl Physiol (1985). 2022; 132(5):1145-1153.

PMID: 35323052 PMC: 9054255. DOI: 10.1152/japplphysiol.00332.2021.


Locomotor Muscles in COPD: The Rationale for Rehabilitative Exercise Training.

Marillier M, Bernard A, Verges S, Neder J Front Physiol. 2020; 10:1590.

PMID: 31992992 PMC: 6971045. DOI: 10.3389/fphys.2019.01590.


Specific motor cortex hypoexcitability and hypoactivation in COPD patients with peripheral muscle weakness.

Alexandre F, Heraud N, Tremey E, Oliver N, Bourgouin D, Varray A BMC Pulm Med. 2020; 20(1):1.

PMID: 31900129 PMC: 6942311. DOI: 10.1186/s12890-019-1042-0.